- Home
- AYTU vs HKPD Comparison
AYTU vs HKPD Comparison
Compare AYTU & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- HKPD
- Stock Information
- Founded
- AYTU N/A
- HKPD 2016
- Country
- AYTU United States
- HKPD Hong Kong
- Employees
- AYTU N/A
- HKPD N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- HKPD Other Pharmaceuticals
- Sector
- AYTU Health Care
- HKPD Health Care
- Exchange
- AYTU Nasdaq
- HKPD Nasdaq
- Market Cap
- AYTU 19.7M
- HKPD 20.9M
- IPO Year
- AYTU N/A
- HKPD 2025
- Fundamental
- Price
- AYTU $2.36
- HKPD $1.35
- Analyst Decision
- AYTU Strong Buy
- HKPD
- Analyst Count
- AYTU 2
- HKPD 0
- Target Price
- AYTU $10.00
- HKPD N/A
- AVG Volume (30 Days)
- AYTU 77.6K
- HKPD 9.1M
- Earning Date
- AYTU 11-12-2025
- HKPD 01-01-0001
- Dividend Yield
- AYTU N/A
- HKPD N/A
- EPS Growth
- AYTU N/A
- HKPD N/A
- EPS
- AYTU N/A
- HKPD N/A
- Revenue
- AYTU $81,659,000.00
- HKPD $20,313,818.00
- Revenue This Year
- AYTU N/A
- HKPD N/A
- Revenue Next Year
- AYTU $2.00
- HKPD N/A
- P/E Ratio
- AYTU $12.93
- HKPD N/A
- Revenue Growth
- AYTU 0.41
- HKPD 21.72
- 52 Week Low
- AYTU $0.95
- HKPD $0.81
- 52 Week High
- AYTU $2.85
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- AYTU 55.26
- HKPD 54.78
- Support Level
- AYTU $2.21
- HKPD $1.00
- Resistance Level
- AYTU $2.38
- HKPD $1.65
- Average True Range (ATR)
- AYTU 0.13
- HKPD 0.29
- MACD
- AYTU 0.01
- HKPD 0.01
- Stochastic Oscillator
- AYTU 73.08
- HKPD 22.35
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.